Abstract:Cytochrome P450 (CYP) enzymes are haem-containing proteins which are mainly involved in the oxidative metabolism of various chemicals. CYP enzymes can be affected by co-administrated drugs, environmental factors, disease states and genetic polymorphism, leading to differing degrees of individual variability of CYP activity which can induce the adverse effect of drugs or result in the failure of a drug therapy with varying severity. In this arena, fluorescent probes can serve as useful molecular tools to selectively detect CYP activity, facilitated by their intrinsic sensitivity and capacity for rapid, real-time and in situ monitoring as well as high-throughput screening. Therefore, the design of enzymatic activity reporters serving as the CYP subtype-specific probes, has stimulated widespread interest. This review covers the design principles for probes and systemically summarizes recent advances in the development of fluorescent probes for CYP isoforms including CYP1A, CYP1A1, CYP2C9, CYP2D6, CYP2J2, CYP3A, CYP3A4, CYP3A7, CYP4A11, CYP4F12 and CYP4F3B, and also probes for detecting the reduction ability of CYP, then categorizes these molecular tools according to the detection strategy or interaction models for the key CYP isoforms, such as dealkylation, hydroxylation or reduction reactions. In addition, challenges and future perspectives in the development of selective and sensitive fluorescent probes of CYP are discussed.

What problem does this paper attempt to address?

The paper primarily discusses the design, development, and application of fluorescent probes for detecting and imaging Cytochrome P450 (CYP) enzymes. CYP enzymes are a class of heme-containing proteins that are mainly involved in the oxidative metabolism of various chemicals. Since CYP enzyme activity can be influenced by co-administered drugs, environmental factors, disease states, and genetic polymorphisms, leading to interindividual differences in CYP activity, this may cause adverse drug reactions or therapeutic failures. Therefore, developing fluorescent probes that can selectively detect CYP activity is of great significance for studying drug interactions and diagnosing and treating CYP-related diseases. The article first introduces the basic concepts and classification of CYP enzymes and their important roles in drug metabolism. It also provides an overview of the catalytic mechanisms of CYP enzymes in drug metabolism and biotransformation. Subsequently, the paper reviews in detail the methods and techniques for designing fluorescent probes for different CYP subtypes (such as CYP1A, CYP2C9, CYP2D6, etc.), including the design principles, structural features of these probes, and how they generate detectable fluorescence signal changes through specific metabolic reactions (such as dealkylation, hydroxylation, or reduction reactions). Specifically, the fluorescent probes mentioned in the paper include but are not limited to: - Two-photon ratio fluorescent probes for detecting CYP1A (especially CYP1A1). - Firefly luciferin derivatives for detecting CYP2C9. - 7-Methoxy-4-(aminomethyl)coumarin derivatives for detecting CYP2D6. - Near-infrared fluorescent probes for detecting CYP2J2. - Coumarin core-based fluorescent probes for detecting CYP3A4. Finally, the paper discusses the challenges and future research directions in developing highly sensitive and specific fluorescent probes. These fluorescent probes have a wide range of applications, not only for monitoring changes in CYP enzyme activity in vitro but also for imaging CYP enzyme activity in live cells, tissue slices, and even live animals. This helps to gain a deeper understanding of the dynamic relationship between CYP enzyme activity and drug metabolism, as well as to explore the functional changes of CYP enzymes under physiological and pathological conditions.

Fluorescent probes for the detection and imaging of Cytochrome P450